Recent Finacing
Recent Raise
Scope Biosciences develops ScopeDx, a Type III CRISPR-Cas-based molecular diagnostic platform for on-site, lab-agnostic detection of plant, seed, veterinary, and human pathogens across agri-food and clinical settings.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Scope Biosciences.
